Bausch Health
317 hedge funds and large institutions have $3.06B invested in Bausch Health in 2017 Q2 according to their latest regulatory filings, with 52 funds opening new positions, 107 increasing their positions, 88 reducing their positions, and 61 closing their positions.
57% more capital invested
Capital invested by funds: $1.95B → $3.06B (+$1.11B)
38% more funds holding in top 10
Funds holding in top 10: 8 → 11 (+3)
22% more repeat investments, than reductions
Existing positions increased: 107 | Existing positions reduced: 88
0.01% less ownership
Funds ownership: 50.93% → 50.93% (-0.01%)
3% less funds holding
Funds holding: 327 → 317 (-10)
15% less first-time investments, than exits
New positions opened: 52 | Existing positions closed: 61
21% less call options, than puts
Call options by funds: $445M | Put options by funds: $564M
Top Buyers
Top Sellers
| 1 |
JG
Jefferies Group
New York
|
-$59.4M |
| 2 |
DSA
Davis Selected Advisers
Tucson,
Arizona
|
-$43.2M |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$30.6M |
| 4 |
SAMH
Shanda Asset Management Holdings
Tortola,,
British Virgin Islands
|
-$25.8M |
| 5 |
DM
Deerfield Management
New York
|
-$16.5M |
BHC Hedge Fund Activity: Q2 2017 in Review
317 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Bausch Health (BHC) for Q2 2017, worth a combined $3.06B — up 57% from $1.95B a quarter earlier.
Sellers outnumbered buyers: 61 funds closed out of BHC and 52 opened new positions — a net loss of 9 holders — while 88 trimmed existing stakes and 107 added.
The largest buyer was Connor, Clark & Lunn Investment Management (CC&L), adding an estimated $40.8M. The largest seller was Jefferies Group, cutting an estimated $59.4M.
- 317 institutional investors held Bausch Health (BHC) as of Q2 2017, down from 327 in Q1 2017.
- Funds reported $3.06B of Bausch Health stock for Q2 2017, up 57% quarter-over-quarter.
- 52 funds opened new Bausch Health positions in Q2 2017 and 61 closed out, a net change of -9 holders.
- The largest Bausch Health buyer in Q2 2017 was Connor, Clark & Lunn Investment Management (CC&L), an estimated $40.8M added.
- The largest Bausch Health seller in Q2 2017 was Jefferies Group, an estimated $59.4M sold.
Based on aggregated 13F filings for Q2 2017.